Vivanza Biosciences Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 5.75 | 45.01 | 53.74 |
| Operating Expense | 5.80 | 44.76 | 53.23 |
| Net Profit | -0.27 | 0.16 | 0.46 |
| Net Profit Margin | -4.70% | 0.36% | 0.86% |
| Earning Per Share | -0.07 | 0.04 | 0.12 |
| EBIDTA | -0.05 | 0.25 | 0.51 |
| Effective Tax Rate | -280% | 0% | 0% |
Particulars
Mar 2026
Revenue5.75
Operating Expense5.80
Net Profit-0.27
Net Profit Margin-4.70
Earning Per Share-0.07
EBIDTA-0.05
Effective Tax Rate-280
